CV Sciences (CVSI) Cash from Operations (2011 - 2026)
CV Sciences' (CVSI) quarterly Cash from Operations came in at 101000.0 in Q1 2026, up 224.69% year-on-year from 31106.46 in Q1 2025, and up 132.9% quarter-over-quarter from 307000.0 in Q4 2025.
CV Sciences (CVSI) Cash from Operations (2011 - 2026) Analysis & Trends
CV Sciences has disclosed Cash from Operations across 16 years of filings, most recently posting 101000.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 101000.0, up 224.69% year-over-year; the trailing twelve-month figure through Mar 2026 was 225000.0 (up 46.93% YoY), and the FY2025 annual result was 407000.0, up 52.73% from the prior year.
- Cash from Operations came in at 101000.0 for Q1 2026 at CV Sciences, up from 307000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 1411000.0 in Q2 2023 to a low of 1169000.0 in Q2 2022.
- The 5-year median for Cash from Operations is 114000.0 (2023), against an average of 47000.0.
- Across the five-year window, Cash from Operations sank 542.11% in 2024 and jumped 603.51% in 2025, its largest moves.
- CV Sciences' Cash from Operations stood at 210000.0 in 2022, then plunged by 154.29% to 114000.0 in 2023, then slumped by 43.86% to 164000.0 in 2024, then tumbled by 87.2% to 307000.0 in 2025, then jumped by 132.9% to 101000.0 in 2026.
- The last three Cash from Operations figures came in at 101000.0 (Q1 2026), 307000.0 (Q4 2025), and 306000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 89.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 125.13 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | 101,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101,000.00 |
| Mar 31, 2026 | 101,000.00 |
| Dec 31, 2025 | -307,000.00 |
| Dec 31, 2025 | -307,000.00 |
| Sep 30, 2025 | -306,000.00 |
| Sep 30, 2025 | -306,000.00 |
| Jun 30, 2025 | 287,000.00 |
| Jun 30, 2025 | 287,000.00 |
| Mar 31, 2025 | -81,000.00 |
| Mar 31, 2025 | -81,000.00 |
| Dec 31, 2024 | -164,000.00 |
| Dec 31, 2024 | -164,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Jun 30, 2024 | -57,000.00 |
| Jun 30, 2024 | -57,000.00 |
| Mar 31, 2024 | -518,000.00 |
| Mar 31, 2024 | -518,000.00 |
| Dec 31, 2023 | -114,000.00 |
| Dec 31, 2023 | -114,000.00 |